Cart
sales@molnova.com
PI4KA inhibitor A1
CAS No. 1416334-69-4
PI4KA inhibitor A1( GSK-A1 )
Catalog No. M11735 CAS No. 1416334-69-4
PI4KA inhibitor A1 (GSK-A1) is a highly specific and potent inhibitor of PI4KA.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 151 | Get Quote |
|
| 10MG | 302 | Get Quote |
|
| 25MG | 537 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePI4KA inhibitor A1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPI4KA inhibitor A1 (GSK-A1) is a highly specific and potent inhibitor of PI4KA.
-
DescriptionPI4KA inhibitor A1 (GSK-A1) is a highly specific and potent inhibitor of PI4KA.
-
In Vitro——
-
In Vivo——
-
SynonymsGSK-A1
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI4K
-
RecptorPI4K
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1416334-69-4
-
Formula Weight574.631
-
Molecular FormulaC29H27FN6O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 2 mg/mL (3.48 mM)
-
SMILESO=S(C1=CC(C2=CC=C3C(N(C4=CC=C(N5CCOCC5)C=C4)C(N)=N3)=C2)=CN=C1OC)(NC6=CC=CC=C6F)=O
-
Chemical Name5-(2-amino-1-(4-morpholinophenyl)-1H-benzo[d]imidazol-6-yl)-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bojjireddy N, et al. J Biol Chem. 2014 Feb 28;289(9):6120-32.
2. Alvarez-Prats A, et al. Cell Rep. 2018 Jun 5;23(10):2881-2890.
molnova catalog
related products
-
BQR-695
BQR-695 (NVP-BQR695) is a highly potent, selective PI4KIIIβ inhibitor that has high potency against both the human (IC50?=?80 nM) and PvPI4K (IC50=3.5 nM).
-
UCT943
UCT943 (UCT-943) is a potent, selective, next generation Plasmodium falciparum PI4K inhibitor with IC50 of 23 nM.
-
PI-273
PI-273 (PI273) is a potent, specific, substrate-competitive small molecule inhibitor of PI4KIIα with IC50 of 0.47 uM.
